Contrave doesn’t produce meaningful weight loss for everyone, and there are several concrete reasons why it may not be working for you. Some are fixable, like not reaching the full dose or eating habits that interfere with absorption. Others are biological: your brain chemistry may simply not respond well to this particular drug combination. The clearest benchmark is this: if you haven’t lost at least 5% of your starting body weight after 12 weeks at the full maintenance dose, the FDA prescribing guidelines recommend stopping the medication because continued use is unlikely to produce results.
You May Not Be at the Full Dose Yet
Contrave uses a four-week ramp-up schedule. You start with one tablet in the morning during week one, add a second tablet in the evening during week two, increase to two in the morning and one at night during week three, and finally reach the full dose of two tablets twice daily at the start of week four. That full maintenance dose is 32 mg of naltrexone and 360 mg of bupropion per day.
If you’re still in the first few weeks, you’re not yet taking enough medication for it to do its job. And many people struggle to complete the ramp-up because of side effects, particularly nausea, which is the most commonly reported issue. If nausea or other side effects have kept you at a lower dose, you may never have given the drug a fair trial at its effective level. The 12-week evaluation window starts counting from when you reach that full four-tablet-per-day maintenance dose, not from your first pill.
How Contrave Actually Works
Understanding what this drug targets helps explain why it fails for some people. Contrave works on appetite-regulating neurons in the brain. Bupropion, a dopamine and norepinephrine reuptake inhibitor, stimulates neurons that suppress hunger and increase energy expenditure. But those same neurons have a built-in off switch: they release natural opioids that dial themselves back down. Naltrexone blocks that off switch, keeping the appetite-suppressing signal active longer.
Neither drug works well for weight loss on its own. Clinical trials of naltrexone alone for obesity in the 1980s were unsuccessful, and bupropion by itself produces only minimal weight reduction in people with obesity. It’s specifically the combination that amplifies the effect on those hunger-regulating neurons. This also means the drug primarily targets the “wanting to eat” side of the equation. If your weight is driven more by metabolic factors, hormonal imbalances, or conditions like insulin resistance rather than by appetite and food reward, Contrave may not address your particular biology.
Genetics Play a Real Role
Researchers are actively investigating why some people respond to Contrave and others don’t, and genetics appears to be a significant factor. One area of focus is a genetic variant called Taq1A, located near the gene that controls dopamine receptors in the brain. About 45% of the population carries at least one copy of this variant, and those carriers have 30 to 40% fewer dopamine receptors in their brains.
This matters because bupropion works by boosting dopamine signaling to activate those appetite-suppressing neurons. In theory, people with fewer dopamine receptors might actually benefit more from the drug’s boost, but other genetic combinations could blunt the response entirely. Variants in the FTO gene, which is strongly linked to obesity risk, also appear to alter how dopamine reward signaling works. The bottom line: obesity has many different underlying causes, and a drug that targets one pathway won’t work for everyone. This isn’t a failure on your part. It’s a mismatch between the drug’s mechanism and your biology.
High-Fat Meals Can Interfere
One easily correctable problem: taking Contrave with a high-fat meal. The prescribing information explicitly warns against this because high-fat food changes how the drug is absorbed. If you’re consistently taking your doses alongside fatty meals, you may be altering the medication’s effectiveness or worsening side effects in ways that undermine your results. Take it with food if needed, but avoid meals heavy in fat.
The 12-Week Decision Point
Contrave has a built-in pass/fail test. After 12 weeks at the full maintenance dose of four tablets per day, you should have lost at least 5% of your baseline body weight. For someone who started at 220 pounds, that’s 11 pounds. For someone at 180 pounds, that’s 9 pounds. If you haven’t hit that threshold, the clinical evidence says continuing the medication is unlikely to produce meaningful long-term results.
This is important to track honestly. The 5% benchmark isn’t an aspirational goal. It’s the minimum indicator that the drug is working on your appetite and reward pathways at all. People who don’t reach this mark in the first 12 weeks rarely catch up later with continued use. If you’re close but not quite there, talk to your prescriber, but if you’ve seen little to no change on the scale after three months at full dose, the drug likely isn’t the right fit.
Diet and Exercise Still Matter
Contrave is approved specifically as an add-on to a reduced-calorie diet and increased physical activity, not as a replacement for them. The drug reduces appetite and cravings, which makes it easier to stick to a calorie deficit, but it doesn’t create that deficit on its own. If your eating patterns haven’t changed meaningfully since starting the medication, or if you’ve increased your intake in other ways (more snacking, larger portions at meals you don’t skip), the appetite suppression may be masking what would otherwise be noticeable hunger while still not producing a calorie gap large enough for weight loss.
Some people also find that Contrave reduces their cravings for certain foods, particularly sweets and high-reward processed foods, but doesn’t change their overall intake because they compensate with other calories. Paying attention to what you’re actually eating, not just whether you feel less hungry, can reveal whether the drug is doing its part while other factors are stalling your progress.
When the Drug Simply Isn’t Enough
Contrave produces moderate weight loss compared to newer medications. Even in clinical trials where participants also followed diet and exercise programs, the results were modest. For people with significant amounts of weight to lose or those whose obesity involves strong metabolic or hormonal components, Contrave’s mechanism of curbing appetite through dopamine and opioid pathways may not be powerful enough. GLP-1 receptor agonists, which work through entirely different gut hormone pathways, tend to produce substantially greater weight loss and may be worth discussing with your prescriber as an alternative.
It’s also worth noting that some medications can counteract Contrave’s effects. Certain antidepressants, antipsychotics, and corticosteroids promote weight gain through mechanisms that appetite suppression alone can’t overcome. If you’re taking other medications, they could be working against your weight loss efforts in ways that Contrave simply can’t compensate for.